Related references
Note: Only part of the references are listed.Regulation of Tak1 alternative splicing by splice-switching oligonucleotides
Donghu Zhou et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Non-Smad Signaling Pathways of the TGF-β Family
Ying E. Zhang
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2017)
Post-Translational Modifications of the TAK1-TAB Complex
Yusuke Hirata et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Transforming Growth Factor-β (TGF-β) Directly Activates the JAK1-STAT3 Axis to Induce Hepatic Fibrosis in Coordination with the SMAD Pathway
Liu-Ya Tang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
Tsukasa Shibue et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
TGF-β Family Signaling in Tumor Suppression and Cancer Progression
Joan Seoane et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2017)
Targeting TGF-β Signaling for Therapeutic Gain
Rosemary J. Akhurst
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2017)
Direct Regulation of Alternative Splicing by SMAD3 through PCBP1 Is Essential to the Tumor-Promoting Role of TGF-β
Veenu Tripathi et al.
MOLECULAR CELL (2016)
Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
Giampaolo Bianchini et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
TGF-β Signaling from Receptors to Smads
Akiko Hata et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2016)
Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance
Kari R. Fischer et al.
NATURE (2015)
Signaling pathway cooperation in TGF-β-induced epithelial-mesenchymal transition
Rik Derynck et al.
CURRENT OPINION IN CELL BIOLOGY (2014)
Development of Therapeutic Splice-Switching Oligonucleotides
Petra Disterer et al.
HUMAN GENE THERAPY (2014)
Transforming Growth Factor (TGF)-β-activated Kinase 1 (TAK1) Activation Requires Phosphorylation of Serine 412 by Protein Kinase A Catalytic Subunit α (PKACα) and X-linked Protein Kinase (PRKX)
Chuan Ouyang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
RBFOX2 Is an Important Regulator of Mesenchymal Tissue-Specific Splicing in both Normal and Cancer Tissues
Julian P. Venables et al.
MOLECULAR AND CELLULAR BIOLOGY (2013)
MED12 Controls the Response to Multiple Cancer Drugs through Regulation of TGF-β Receptor Signaling
Sidong Huang et al.
CELL (2012)
Polyubiquitination of Transforming Growth Factor β (TGFβ)-associated Kinase 1 Mediates Nuclear Factor-κB Activation in Response to Different Inflammatory Stimuli
Anahita Hamidi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Tissue-Specific Alternative Splicing of Tak1 Is Conserved in Deuterostomes
Julian P. Venables et al.
MOLECULAR BIOLOGY AND EVOLUTION (2012)
TGFβ signalling in context
Joan Massague
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
An EMT-Driven Alternative Splicing Program Occurs in Human Breast Cancer and Modulates Cellular Phenotype
Irina M. Shapiro et al.
PLOS GENETICS (2011)
Autoactivation of Transforming Growth Factor β-activated Kinase 1 Is a Sequential Bimolecular Process
Roland Scholz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
A. Singh et al.
ONCOGENE (2010)
An RNA code for the FOX2 splicing regulator revealed by mapping RNA-protein interactions in stem cells
Gene W. Yeo et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2009)
TGF-β coordinately activates TAK1/MEK/AKT/NFkB and SMAD pathways to promote osteoclast survival
Anne Gingery et al.
EXPERIMENTAL CELL RESEARCH (2008)
NF-κB in carcinoma therapy and prevention
Matthew Brown et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2008)
Defining the regulatory network of the tissue-specific splicing factors Fox-1 and Fox-2
Chaolin Zhang et al.
GENES & DEVELOPMENT (2008)
Jun N-terminal kinase 1 regulates epithelial-to-mesenchymal transition induced by TGF-β1
John F. Alcorn et al.
JOURNAL OF CELL SCIENCE (2008)
TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-β
Motozo Yamashita et al.
MOLECULAR CELL (2008)
The type I TGF-β receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner
Alessandro Sorrentino et al.
NATURE CELL BIOLOGY (2008)
Structural basis for the interaction of TAK1 kinase with its activating protein TAB1
K Brown et al.
JOURNAL OF MOLECULAR BIOLOGY (2005)
Syngeneic mouse mammary carcinoma cell lines: Two closely related cell lines with divergent metastatic behavior
AD Borowsky et al.
CLINICAL & EXPERIMENTAL METASTASIS (2005)
NF-κB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression
MA Huber et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Role of the TAB2-related protein TAB3 in IL-1 and TNF signaling
T Ishitani et al.
EMBO JOURNAL (2003)
Transient activation of NF-κB through a TAK1/IKK kinase pathway by TGF-β1 inhibits AP-1/SMAD signaling and apoptosis:: implications in liver tumor formation
M Arsura et al.
ONCOGENE (2003)
TGF-β receptor-activated p38 MAP kinase mediates smad-independent TGF-β responses
L Yu et al.
EMBO JOURNAL (2002)
TAK1 is a ubiquitin-dependent kinase of MKK and IKK
C Wang et al.
NATURE (2001)
Alternative splicing and gene structure of the transforming growth factor β-activated kinase 1
CE Dempsey et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION (2000)
Phosphorylation-dependent activation of TAK1 mitogen-activated protein kinase kinase kinase by TAB1
H Sakurai et al.
FEBS LETTERS (2000)
TAB2, a novel adaptor protein, mediates activation of TAK1 MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway
G Takaesu et al.
MOLECULAR CELL (2000)
TAK1 mitogen-activated protein kinase kinase kinase is activated by autophosphorylation within its activation loop
K Kishimoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)